Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide slows how quickly food leaves your stomach, which changes your relationship with eating in ways that catch many people off guard. The right food choices while taking tirzepatide can meaningfully reduce nausea, support steady weight loss, and help you get enough protein even when your appetite has dropped sharply. These medicines are prescription-only, and a prescriber will discuss dietary guidance with you as part of your clinical assessment — but understanding the principles beforehand helps. Our clinical team regularly answers questions about eating on tirzepatide, so this page pulls together the evidence-based picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The mechanism matters here. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and one of their combined effects is a significant slowdown in gastric emptying. Food that would ordinarily leave your stomach in two or three hours may sit there considerably longer. This is useful for reducing appetite and flattening blood-sugar spikes, but it also means your stomach has far less tolerance for the kinds of meals that would previously have been fine.
High-fat foods are the main culprit. Fat already takes longer to digest than carbohydrate or protein, and when gastric emptying is already slowed, a creamy pasta dish or a takeaway can trigger nausea, bloating, or reflux that lasts hours. Eating quickly compounds the problem, portions that feel normal before treatment can feel overwhelming once tirzepatide is on board. The food noise reduction that many people notice is a separate phenomenon, driven by the brain's appetite circuits, but the physical tolerance issue is distinct and worth planning for, especially in the days after a dose increase.
Carbonated drinks, spicy food and very rich sauces are commonly reported as triggers. None of this is universal (tirzepatide's effects vary between individuals) but these are the patterns that come up most often. The NHS tirzepatide medicines page outlines the GI side effects associated with treatment and is worth reading in full before you start.
Because appetite drops so much, the question of what to eat becomes more important than how much. Protein adequacy is the priority. When the body loses weight quickly, muscle can go alongside fat unless protein intake stays high enough to signal that muscle should be preserved. Most clinical guidance for people on GLP-1 medicines points toward around 1.2–1.6g of protein per kilogram of body weight per day, though your prescriber or a dietitian will give you a target suited to your situation.
Practical protein sources that tend to sit well on tirzepatide are those that are easy to eat in small amounts: Greek yoghurt, eggs, fish, cottage cheese, chicken, and legumes. Soft textures generally cause less discomfort than very fibrous or dense foods eaten in quantity. The foods that tend to work best are broadly those that are high in protein or fibre, moderate in fat, and easy to eat slowly.
Fibre matters too. Constipation is a common side effect, partly because food moves through the gut more slowly overall. Vegetables, oats, pulses, and adequate water intake help. Small, frequent meals typically cause less discomfort than two or three large ones, not because of any special rule about tirzepatide, but simply because a stomach with slowed emptying handles smaller volumes more comfortably.
For a structured breakdown of meal ideas, the what to eat on Mounjaro guide covers practical meal planning alongside treatment.
There is no official list of banned foods. What exists is a practical hierarchy of foods that tend to cause the most trouble, and it is worth knowing it before your first pen arrives. High-fat meals (particularly those heavy in saturated fat, like fried food, pastries, and full-fat dairy in large portions) are the most consistently reported triggers for nausea and reflux. Very sugary drinks and foods can also cause problems, in part because rapid sugar delivery alongside slowed gastric emptying can produce nausea and light-headedness in some people.
Alcohol is worth a specific note. Tirzepatide can alter how alcohol is absorbed and tolerated. The NHS advises discussing alcohol intake with your prescriber, not because a glass of wine is categorically off the table, but because tolerance can change unexpectedly, and some people find they feel the effects of alcohol much more quickly than before treatment. This is a conversation for your clinical review, not something to test informally.
The question of tirzepatide in food (whether the medicine itself interacts with specific ingredients) occasionally comes up. Tirzepatide is a subcutaneous injection, not an oral medicine, so it is not affected by food in the way that oral drugs can be. The interaction runs the other way: the medicine changes how your body processes food, not vice versa. For more detail on specific foods and tirzepatide, this page on tirzepatide and specific food types goes deeper.
The short answer is yes, though not by changing the medicine's pharmacology. Tirzepatide's mechanism is fixed once it is injected, but whether you lose weight (and how much) is shaped by what happens alongside the appetite reduction it produces. Clinical trials such as SURMOUNT-1, which enrolled adults with obesity over 72 weeks, included a reduced-calorie diet and increased physical activity as part of the treatment protocol. The weight loss figures from those trials (around 20% average reduction at the highest dose) were achieved in that context, not on tirzepatide alone. The SURMOUNT-1 trial published in the New England Journal of Medicine is the primary evidence base behind NICE's recommendation of tirzepatide for weight management.
That said, the medicine does a lot of heavy lifting on appetite. Many people find that food choices improve almost automatically, the pull toward high-calorie snacks weakens, portions feel satisfying at a smaller size, and the compulsive quality of eating changes. If you are still feeling hungry on tirzepatide, there are specific reasons why that can happen and practical steps worth exploring. For a fuller picture of how tirzepatide is used for weight management, the Mounjaro overview covers the licence, the evidence, and what treatment involves. If you are considering starting treatment, speaking to our prescribers is the next step, a clinical review looks at your full picture before any treatment is recommended.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.